W
Wen Tang
Researcher at Peking University
Publications - 36
Citations - 687
Wen Tang is an academic researcher from Peking University. The author has contributed to research in topics: Peritoneal dialysis & Kidney disease. The author has an hindex of 14, co-authored 35 publications receiving 457 citations. Previous affiliations of Wen Tang include University of Queensland & Princess Alexandra Hospital.
Papers
More filters
Journal ArticleDOI
Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET)
Fang Wang,Chao Yang,Jianyan Long,Xinju Zhao,Wen Tang,Dongliang Zhang,Kunhao Bai,Zaiming Su,Bixia Gao,Hong Chu,Jinwei Wang,Xiaoyu Sun,Song Wang,Li Zuo,Yue Wang,Feng Yu,Haibo Wang,Luxia Zhang,Ming-Hui Zhao +18 more
TL;DR: By integrating and mining national patient-level administrative or claim databases, this work is able to provide a comprehensive description of the burden of CKD and end stage kidney disease in China, which could be used by multiple stakeholders with interests in kidney disease.
Journal ArticleDOI
China Kidney Disease Network (CK-NET) 2016 Annual Data Report
Luxia Zhang,Ming-Hui Zhao,Ming-Hui Zhao,Ming-Hui Zhao,Li Zuo,Yue Wang,Feng Yu,Feng Yu,Hong Zhang,Hong Zhang,Haibo Wang,Rui Chen,Rui Chen,Hong Chu,Hong Chu,Xinwei Deng,Xinwei Deng,Lanxia Gan,Bixia Gao,Bixia Gao,Yifang Jiang,Yifang Jiang,Lili Liu,Lili Liu,Jianyan Long,Ying Shi,Zaiming Su,Xiaoyu Sun,Wen Tang,Fang Wang,Fang Wang,Huai-Yu Wang,Jinwei Wang,Jinwei Wang,Song Wang,Chao Yang,Chao Yang,Dongliang Zhang,Xinju Zhao,Liren Zheng,Zhiye Zhou +40 more
Journal ArticleDOI
Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease
Wen Tang,Wen Tang,Stephen P. McDonald,Carmel M. Hawley,Sunil V. Badve,Neil Boudville,Fiona G. Brown,Philip A. Clayton,Scott B. Campbell,Janak de Zoysa,David W. Johnson +10 more
TL;DR: Anti-GBM disease was an uncommon cause of ESRD, and not associated with altered risks of dialysis, transplant or first renal allograft survival, and was not altered compared to other diseases requiring a renal transplant.
Journal ArticleDOI
The Outcomes of Patients with ESRD and ANCA-Associated Vasculitis in Australia and New Zealand
Wen Tang,Bhadran Bose,Stephen P. McDonald,Carmel M. Hawley,Sunil V. Badve,Neil Boudville,Fiona G. Brown,Philip A. Clayton,Philip A. Clayton,Scott B. Campbell,Chen Au Peh,David W. Johnson +11 more
TL;DR: Compared with ESRD patients without AAV, those with GPA have comparable renal replacement therapy outcomes, whereas MPA patients have comparable dialysis survival but poorer renal transplant allograft and patient survival rates.
Journal ArticleDOI
End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases
Wen Tang,Wen Tang,Stephen P. McDonald,Carmel M. Hawley,Sunil V. Badve,Neil Boudville,Fiona G. Brown,Philip A. Clayton,Scott B. Campbell,Janak de Zoysa,David W. Johnson +10 more
TL;DR: Amyloidosis was associated with poor patient survival following dialysis and/or renal transplantation, poor renal allografted survival and a significant incidence of disease recurrence in the allograft.